Skin Clearance Tops Psoriasis Treatment Choices
A multicountry study found patients with systemic-eligible psoriasis weigh skin clearance most heavily when choosing therapy.
Updated on Nov. 4, 2026 in Diabetes
Live Poll
Would you accept a medication with more side effects if it cleared your skin faster?
Patients with moderate to severe psoriasis prioritized skin clearance over other treatment attributes in a discrete-choice study of 202 participants from the UK, US and Australia. Oral versus injectable route ranked second in treatment preference.
Why it matters
The number of systemic options for moderate to severe psoriasis keeps growing, making patient preferences more important for shared decision-making between clinicians and patients. Understanding which attributes matter most may help tailor treatment as choices multiply.
The study, which used a multinomial logit model across 7 treatment attributes, found skin clearance at 52 weeks carried 20.9% relative importance versus 15.4% for oral vs subcutaneous route and 4.0% for oral fasting requirements. More than one-third (35%) of participants said they would switch to a treatment with no acne risk, though full cohort results are still pending.
The players
Fall Clinical Dermatology Conference
An annual dermatology meeting where early ENCOMPASS-PP results were presented, offering clinicians and researchers a venue to review emerging psoriasis treatment data.
The details
Researchers enrolled 202 participants meeting International Psoriasis Council criteria for systemic treatment, with a mean age of 44.8 years and 41.1% female. Participants repeatedly chose between hypothetical treatment profiles, and 43.5% had previously used a biologic while 86.1% had used an oral therapy.
Timeline
Early results were presented on November 4, 2026, at the Fall Clinical Dermatology Conference in Las Vegas, Nevada.
Health Landscape
The findings build on the ENCOMPASS-PP research program, which is generating comparative evidence across biologic and oral psoriasis agents. As that evidence expands, measuring which treatment attributes patients value most gives clinicians a clearer basis for shared decision-making.
For people weighing psoriasis treatments, the findings suggest that how quickly and fully skin clears may matter more than route of administration when comparing options. Patients considering a switch should discuss how these priorities align with their own treatment goals with their clinician.
The takeaway
Patient priorities such as skin clearance speed and treatment route can shape which psoriasis therapy best fits an individual. Discussing these preferences openly with a clinician supports more personalized treatment decisions.
Further reading
For related context on chronic inflammatory and metabolic conditions, see Diabetes.
Source note: This article includes information reported by Hcplive.
Live Poll
Would you accept a medication with more side effects if it cleared your skin faster?
